Ocugen (OCGN) Liabilities and Shareholders Equity (2014 - 2026)

Ocugen (OCGN) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $56.9 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 11.72% year-over-year to $56.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $211.6 million (down 15.15% YoY) and the FY2025 annual result came in at $43.5 million, down 47.22% from the prior year.
• Liabilities and Shareholders Equity climbed to $56.9 million in Q1 2026, from $43.5 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $141.7 million in Q1 2022 to a low of $40.5 million in Q2 2024.
• A 5-year average of $78.5 million and a median of $64.5 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 163.2% — and 2024, when it slumped 54.43%.
• Tracing OCGN's Liabilities and Shareholders Equity over 5 years: stood at $108.6 million in 2022, then sank by 40.58% to $64.5 million in 2023, then gained by 27.72% to $82.4 million in 2024, then slumped by 47.22% to $43.5 million in 2025, then jumped by 30.77% to $56.9 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $56.9 million (Q1 2026), $43.5 million (Q4 2025), and $57.6 million (Q3 2025), per Business Quant data.